GL1X · GenesisL1 explorer

Research workbench

Mycobacterium tuberculosis DPRE1 in complex with inhibitor TCA020

Analyse Mycobacterium tuberculosis DPRE1 in complex with inhibitor TCA020 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5OEQ
Type
protein
Length
843 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Decaprenylphosphoryl-beta-D-ribose oxidase
UniProt
I6X8C4
Ligands
FAD, P95
Pockets
4 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADecaprenylphosphoryl-beta-D-ribose oxidaseprotein42630% helix, 26% strandI6X8C4
BDecaprenylphosphoryl-beta-D-ribose oxidaseprotein41731% helix, 26% strandI6X8C4

Ligands and binding sites

  • FAD · Flavin-adenine dinucleotide · ligand · 2 copies · chains A, B
  • P95 · ~{N}-[3-(pyrimidin-2-ylcarbamoyl)thiophen-2-yl]-[1, 3]thiazolo[4,5-c]pyridine-2-carboxamide · ligand · chains A
  • IMD · Imidazole · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16210.800.8576FAD, P95
25090.780.8561FAD
35400.610.7449empty
41050.340.7320empty

Interfaces

1 interface between chains.

  • A–B · 464 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 5OEQ · Mycobacterium tuberculosis DprE1 in complex with inhibitor TCA020 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.